PRESS RELEASE published on 03/06/2024 at 07:30, 2 years 6 months ago Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic. Evotec and Claris announce acceleration framework to support biotech companies with clinical trials Clinical Trials Claris Ventures Evotec Acceleration Framework Biotech Companies
PRESS RELEASE published on 02/07/2024 at 07:30, 2 years 7 months ago Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV Evotec SE expands partnership with ABL to develop and manufacture broadly neutralising antibodies against HIV, funded by NIAID. The collaboration aims to supply clinical material for ongoing global trials Evotec SE ABL Broadly Neutralising Antibodies HIV NIAID
PRESS RELEASE published on 01/22/2024 at 07:30, 2 years 8 months ago Evotec SE: Invitation to Conference Call Evotec SE is going to hold a conference call to provide a statement and a business update on January 22, 2024, featuring the Chairwoman of Evotec's Supervisory Board and Evotec's CEO. The call will cover the Company's commitment to compliance with Corporate Governance standards and transparent communication, as well as the execution of its existing strategy and recent market developments. For more details, including webcast access and conference call registration, please visit the provided links. Conference Call Business Update Evotec SE Corporate Governance Market Developments
PRESS RELEASE published on 11/08/2023 at 07:00, 2 years 10 months ago Evotec SE reports results for the first nine months 2023 and provides corporate update
PRESS RELEASE published on 11/07/2023 at 07:30, 2 years 10 months ago Evotec and Dewpoint Therapeutics enter strategic partnership in oncology
PRESS RELEASE published on 11/01/2023 at 12:05, 2 years 11 months ago Evotec SE to announce results for the first nine months 2023 on 08 November 2023
PRESS RELEASE published on 10/05/2023 at 07:30, 2 years 11 months ago Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'
PRESS RELEASE published on 09/27/2023 at 07:30, 3 years ago Evotec SE: Launch of partnering agreement to strengthen biotech innovators in shared R&D economy
PRESS RELEASE published on 09/26/2023 at 13:35, 3 years ago Evotec and Novo Nordisk launch LAB eN² to accelerate translation in cardiometabolic diseases
PRESS RELEASE published on 08/29/2023 at 07:00, 3 years 1 month ago Evotec SE reports results for the first half-year 2023 and provides corporate updates
Published on 10/03/2026 at 02:35, 10 hours 37 minutes ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 23 hours 22 minutes ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/02/2026 at 23:55, 13 hours 17 minutes ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 16 hours 48 minutes ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 17 hours 25 minutes ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 19:00, 18 hours 12 minutes ago INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 10/02/2026 at 18:00, 19 hours 12 minutes ago EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 17:45, 19 hours 27 minutes ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 19 hours 27 minutes ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 19 hours 37 minutes ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 19 hours 42 minutes ago Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 19 hours 42 minutes ago Aéroports de Paris SA - Calendrier financier 2027